WUXIHYBRID

Serial Number 90620771
601

Registration Progress

Application Filed
Apr 2, 2021
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

WUXIHYBRID

Basic Information

Serial Number
90620771
Filing Date
April 2, 2021
Abandonment Date
December 1, 2021
Drawing Code
3000

Status Summary

Current Status
Inactive
Status Code
601
Status Date
Dec 2, 2021
Classes
040 042

Rights Holder

WuXi Biologics Ireland Limited

99
Address
One Spencer Dock
North Wall Quay
Dublin 1 D01
IE

Ownership History

WuXi Biologics Ireland Limited

Original Applicant
99
Dublin 1 IE

Legal Representation

Attorney
Victoria Friedman

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

13 events
Date Code Type Description Documents
Dec 2, 2021 ABN1 O ABANDONMENT - EXPRESS MAILED Loading...
Dec 2, 2021 MAB1 E ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT Loading...
Dec 1, 2021 EXAR I TEAS EXPRESS ABANDONMENT RECEIVED Loading...
Nov 22, 2021 CNRT R NON-FINAL ACTION WRITTEN Loading...
Nov 22, 2021 GNRT O NON-FINAL ACTION E-MAILED Loading...
Nov 22, 2021 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Nov 20, 2021 CNRT R NON-FINAL ACTION WRITTEN Loading...
Nov 20, 2021 GNRT F NON-FINAL ACTION E-MAILED Loading...
Nov 20, 2021 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Nov 17, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 13, 2021 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Jul 11, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 6, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 040
Custom manufacture of pharmaceuticals, biopharmaceuticals, nutraceuticals, vitamins by pharmaceutical compounders
First Use Anywhere: 0
First Use in Commerce: 0
Class 042
Product development for others; Pharmaceutical drug development services; Scientific research and development; pharmaceutical research services; Research and development of new products; Consulting services in the field of pharmaceutical technology development; Biochemical research and analysis; Research services for biomedical science; Pharmaceutical preparations and medicines development; Pharmaceutical preparations and medicines development
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Design Mark
The mark consists of the word WuXiHybrid with an eyeball as the dot for the "i's" with a double healix shape that resembles a mouth with teeth connecting the eyes, and the "Y" in thinner text with double lines.

Classification

International Classes
040 042